At UCEF, we ensure that young people remain empowered and well-informed about their sexual and reproductive health. Our goal is to equip them with the knowledge needed to make informed decisions that impact their health and future positively. In alignment with this objective, UCEF conducted a four-week engagement with its first cohort of young people, aged 10 to 22 years, meeting every Saturday throughout April 2025 at the Amoako Atta Foundation. The sessions provided comprehensive education on a range of Sexual and Reproductive Health (SRH) topics, including but not limited to menstrual hygiene, pregnancy and HIV prevention, human rights and responsibilities, healthy relationships, effective communication, and problem-solving skills. We are pleased to report that these sessions were highly impactful, as evidenced by responses collected through pre- and post-tests, as well as the variety and depth of questions asked—both during open discussions and through confidential channels, particularly by young girls. This initiative provided a valuable opportunity for participants to express their views openly, especially espcially on matters that concerns them and issues they are unable to speak out to their parents and guardians about.
When I was 21 I had just finished my second year at Uni studying to be a primary school teacher, which is a career I have always dreamed of achieving. However, during my summer break in August 2017, my world turned upside down when I was diagnosed with an incredibly rare and aggressive cancer called Alveolar Rhabdomyosarcoma, stage 4.
The symptoms were so minimal (agonising back and leg pain) it had made its way around my full body by the time I was diagnosed. Since then I have undergone over 20 cycles of chemotherapy, 50 sessions of radiotherapy and numerous operations to try and stabilise my disease.
I have always dreamed of achieving. However, during my summer break in August 2017, my world turned upside down when I was diagnosed with an incredibly rare and aggressive cancer called Alveolar Rhabdomyosarcoma, stage 4. The symptoms were so minimal (agonising back and leg pain) it had made its way around my full body time I was diagnosed. Since then I have undergone over 20 cycles of chemotherapy, 50 sessions of radiotherapy and numerous operations to try and stabilise my disease.
After endless hours and incredibly late nights of research, we have found that the USA have a trial drug available which works alongside my current chemotherapy.
Founder,Anarkoli Co.
The symptoms were so minimal (agonising back and leg pain) it had made its way around my full body by the time I was diagnosed. Since then I have undergone over 20 cycles of chemotherapy, 50 sessions of radio therapy and numerous operations to try and stabilise my disease. We have now been told that I have stopped responding to the few drugs available for Sarcoma. After endless hours and incredibly late nights of research, we have found that the USA have a trial drug available which works alongside.